Concurrent administration of subtherapeutic doses of amphotericin B and a pentoxifylline analog led to increased survival times in experimental candidiasis in mice (41), whereas amphotericin B increased the expression of IL-1β in human mononuclear cells in vitro (42). Here, IL1B is linked to candidiasis.